Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neutrophil-targeted nanoparticles delivering sivelestat alleviate cerebral ischemia-reperfusion injury by suppressing NETosis.

Materials today. Bio·2026

Same author

Visualizable regulation of brushite mineralization by carboxylated gold nanoclusters: From liquid precursor formation to crystal growth.

Journal of colloid and interface science·2026

Same author

Evaluating the quality and reliability of pulmonary embolism-related short videos on Bilibili and TikTok: A cross-sectional content analysis.

Medicine·2026

Same author

A neutrophil-tumor cascade-targeting Trojan horse for heterobifunctional prodrug delivery to enhance cGAS-STING cancer immunotherapy.

Journal of nanobiotechnology·2026

Same author

Single-cell-based analysis establishes C1QA-mediated promotion of high glucose-induced tubular epithelial injury via ERS in DN.

Gene·2026

Same author

Nanocarriers engineering for efficient NSUN2 silencing and immune responsive therapy in metastatic colorectal cancer.

Materials today. Bio·2026

Search research articles

Related Experiment Video

Updated: Oct 12, 2025

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics.

Menglu Zhu¹, Yi Shi², Yifan Shan¹

¹The Fourth Affiliated Hospital, Zhejiang University School of Medicine, 322000, Yiwu, Zhejiang, People's Republic of China.

Journal of Nanobiotechnology

|November 25, 2021

Summary

Mesoporous polydopamine (MPDA) nanoparticles offer improved drug delivery for cancer therapy. Their unique structure enhances drug loading and enables multi-modal treatments like photothermal and immunotherapy.

Keywords:

Cancer theranostics Immunotherapy MPDA Nanodrug delivery systems Photothermal therapy

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Oct 12, 2025

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Area of Science:

Biomaterials Science
Nanotechnology
Drug Delivery Systems
Cancer Therapeutics

Background:

Polydopamine (PDA) nanoparticles show promise in disease diagnosis and drug delivery due to biocompatibility and photothermal properties.
Traditional PDA nanoparticles have limitations in drug loading and encapsulation, especially for hydrophobic drugs.
Mesoporous materials offer enhanced properties for nanodrug delivery systems.

Purpose of the Study:

To review the preparation methods of mesoporous polydopamine (MPDA) nanoparticles.
To explore the latest applications of MPDA-based nanodrug delivery systems in cancer therapy.
To highlight the potential of MPDA in multi-strategy antitumor therapies.

Main Methods:

Overview of MPDA synthesis and characterization techniques.
Review of literature on MPDA applications in various cancer treatment combinations.
Analysis of MPDA's properties, including porosity, surface area, and photothermal efficiency.

Main Results:

MPDA exhibits a porous structure, high surface area, and efficient light-to-heat conversion.
MPDA-based systems demonstrate efficacy in combined therapies: chemotherapy/radiotherapy, photothermal therapy (PTT) with chemotherapy, PTT with immunotherapy, and PTT with photodynamic/chemodynamic therapy.
MPDA is suitable for cancer theranostics, integrating diagnosis and therapy.

Conclusions:

MPDA nanoparticles overcome the limitations of traditional PDA for drug delivery.
MPDA nanodrug delivery systems offer a versatile platform for advanced, multi-modal cancer treatment strategies.
MPDA holds significant potential for developing innovative antitumor therapies.